CDKN1B and leiomyosarcoma: We sought to investigate the potential of miR-221, miR-320a, miR-133a, and miR-133b, along with their target mRNAs CDKN1B, TGFBR1, and IGF1R, as candidate biomarkers of leiomyosarcoma.